HOXA1 belongs to the HOX family of transcription factors which are key regulators of animal development. Little is known about the molecular pathways controlling HOXA1. Recent data from our group revealed distinct partner proteins interacting with HOXA1. Among them, OGT is an O-linked N-acetylglucosamine (O-GlcNAc) transferase modifying a variety of proteins involved in different cellular processes including transcription. Here, we confirm OGT as a HOXA1 interactor, we characterise which domains of HOXA1 and OGT are required for the interaction, and we provide evidence that OGT post-translationally modifies HOXA1. Mass spectrometry experiments indeed reveal that HOXA1 can be phosphorylated on the AGGTVGSPQYIHHSY peptide and that upon OGT expression, the phosphate adduct is replaced by an O-GlcNAc group.
Shared by all bilaterian animals, HOX proteins constitute an important family of homeodomain transcription factors involved in the control of several developmental processes extending from patterning the embryonic axes to controlling cell differentiation during organogenesis. They are therefore often viewed as 'architect genes' because their mutations cause entire body parts to be misshaped, malformed or mislocated [1] [2] [3] [4] [5] [6] . HOXA1 is a mammalian HOX protein involved in patterning the hindbrain, somitic derivatives, the arterial pole of the heart and the inner ear [7] [8] [9] [10] [11] [12] . Consistently, misexpression or dysfunction of HOXA1 in the mouse leads to several developmental abnormalities and in humans HOXA1 mutations have been identified to cause malformations collectively characterising the so-called HOXA1 syndrome (formerly known as Athabascan Brainstem Dysgenesis Syndrome or Bosley-Salih-Alorainy Syndromes). At adulthood, HOXA1 overexpression has also been associated to cancer, in particular HOXA1 has been identified as a breast oncogene [13] [14] [15] [16] [17] [18] .
While the developmental functions of HOXA1 have been well characterised, it is surprising that the mode of action of HOXA1, i.e. the molecular pathways HOXA1 acts on and the molecular interactions supporting its activities, remain scarcely documented. Numerous target genes of HOXA1 have been identified from distinct in vitro and in vivo models [16, [19] [20] [21] , but only a few of them have been functionally shown to be direct targets. Among them, Epha2 and Hoxb1 have been the most characterised, being both controlled by HOXA1 in the context of hindbrain segmentation [22] [23] [24] [25] [26] . Regarding protein interactions, the only well-known partners of HOXA1 are shared by most mammalian HOX proteins: the PBX proteins. PBX belong to the 'Three Amino acid Loop Extension' (TALE) homeodomain family of transcription factors. The HOX-PBX interaction involves a hexapeptide motif HOX proteins possess N-terminally to the homeodomain [27, 28] . Integrity of this hexapeptide, thus presumably the interaction with PBX, has been shown to be critical for the activity of HOXA1 in vitro as well as in vivo [29] [30] [31] .
To identify other protein partners of HOXA1, a proteome-wide interactomic screen has recently been performed by yeast-two-hybrid. Fifty-nine candidate interactors have been identified, among which 41 were confirmed by bimolecular fluorescence complementation (BiFC) and coprecipitations from live animal cells [32] . This allowed pinpointing pathways HOXA1 may take part in either to achieve its molecular functions or to receive regulatory inputs. Among the interacting proteins, several not related to transcription regulation lifted the veil on unexpected nontranscriptional activities of HOXA1, as recently described in the context of the TNFR-NF-jB pathway for example [18] .
Among the HOXA1 interactors, distinct post-translational modification (PTM) enzymes were identified [32] . The O-linked N-acetylglucosamine (GlcNAc) transferase OGT is, to date, the only reported enzyme able to add an O-GlcNAc group to serines or threonines of nuclear and cytoplasmic proteins. This O-GlcNAc modification is functionally more analogous to protein phosphorylation than the typical O-linked glycosylation taking place in the endoplasmic reticulum and Golgi apparatus. Like phosphorylation, O-GlcNAcylation is very dynamic and it has been reported that O-GlcNAcylation is in competition with phosphorylation in most of its target proteins [33] [34] [35] . The diversity of O-GlcNAcylated proteins brought scientists to consider this modification as making a link between the nutrient state and energetic demand of cells and various cellular pathways like cell signalling, cycling, differentiation, including gene regulation [36, 37] . In that context, OGT has been shown to modulate the activity status of RNA polymerase II by modifying regulatory serines in its C-terminal domain (CTD) [38] [39] [40] . O-GlcNAc adducts are also present on histone proteins indicating OGT contributes to modulate epigenetic regulatory landscapes [41] . OGT interacts with other chromatin modification proteins and transcriptional regulators, like TET proteins (mediate the 5 hydroxy-methylation of cytosines, 5hmC), HCF1 (promotes histone H3 lysine 4 trimethylation, H3K4me3), MLL5 (catalyses H3K4 mono-and di-methylation, H3K4me1/2) and Polycomb proteins (contribute to H2BK119 ubiquitination and H3K27 trimethlyation, H3K27me3) [36, 42] . Finally, transcription factors themselves can be modified by OGT. O-GlcNAcylation of transcription factors modulates their stability, transcriptional activity, intracellular distribution as well as their capacity to bind DNA or to establish protein-protein interactions [33, 43] . Thus, OGT is capable to modulate gene expression by multiple ways, in response to various stimuli.
As a candidate interactor, OGT could affect HOXA1 activity by similar processes [33, 43] . While no PTM has been reported so far for HOXA1, it could be hypothesised that OGT adds O-GlcNAc groups to HOXA1, influences its possible phosphorylation profile and directly affects its activity by either modifying its stability, its subcellular localisation or its transcriptional activity. This together prompted us to confirm and deepen the characterisation of the HOXA1-OGT interaction.
Materials and methods

Plasmid constructs
The plasmids pML-EphA2-r4-Luc [24] , pML-Hoxb1-ARELuc [25] , pCMV-Lacz [44] , the pEXP-FLAG(Nter)-Hoxa2 [45] , pCMV-Pbx1 [30] , pCS2-Prep1 [46] , pEXP-FLAG (Nter)-Hoxa1, pEXP-GST(Nter)-Hoxa1, pEXP-VC155 (Nter)-Hoxa1 [32] , pEXP-FLAG(Nter)-Hoxa1
DNter , pEXP-
FLAG(Nter)-Hoxa1
D11His
, pEXP-FLAG(Nter)-Hoxa1 [30] , and vectors for OGT deletion derivatives were generated from pEXP-GST(Nter)-OGT vectors, by using different primer pairs (Table 1) . The amplified coding sequences were then transferred to Gateway TM vectors as detailed above. The pGIH309 vector corresponds to the previously described pGIH327 plasmid [30] 
Immunofluorescence
One hundred and fifty thousand HEK293T or COS7 cells were seeded on glass coverslips, coated (HEK293T) or not 
Bimolecular fluorescence complementation
Three hundred thousand COS7 cells were seeded on glass coverslips in 24-well plates and were transfected with 250 ng of pEXP-VC155(Nter) and 250 ng of pEXP-VN173 (Nter) plasmids according to the experiment. Cells were rinsed once in PBS and fixed for 20 min with 4% PFA-PBS (#441244, Sigma) at room temperature, 24 h post-transfection. Cells were then rinsed twice (5 min) in TBS-0.1% TritonX100 and once (10 min) with TB. Coverslips were mounted and stained with a solution containing DAPI and Vectashield (#H-1200, Labconsult) to be observed under an epifluorescence microscope (Axioskop 2, Zeiss). Fluorescence quantification was performed by using the IMAGEJ software and tested interactions were considered as positive when the fluorescence emitted in the test was at least three times more intense than in the three control conditions involving empty pDEST-VC155(Nter) and/or pDEST-VN173(Nter) vectors.
Glutathione coprecipitation
Seven hundred thousand HEK293T cells were seeded per well of a 6-well plate and transfected with 1 lg of DNA as described above. Forty-eight hours after transfection, cells were rinsed once with PBS and then lysed in cold IPLS buffer (20 mM TrisHCl pH7.5, 120 mM NaCl, 0.5 mM EDTA, 1x, 0.5% NP40, 10% glycerol) supplemented with 1x Complete TM protease inhibitor (#11873580001, Roche), during 20 min on ice under gentle agitation. Cell lysates were centrifuged 5 min at full speed (16 000 g) in a table centrifuge at 4°C. Expression of FLAG-or GST-fused proteins and b-Actin were analysed by western blotting with a mouse anti-FLAG antibody (#F1804, Sigma), a mouse anti-GST antibody (#G1160, Sigma) and a HRPcoupled mouse anti-b-Actin antibody (#A3854, Sigma), respectively. Fifty lL of glutathione-sepharose beads (#GE17-0756-01, Sigma) was washed three times with cold IPLS and then was added to protein lysates O/N at 4°C on a rotating wheel. Beads were then washed three times with cold IPLS. The first wash was kept to control the abundance of unbound GST-fusion protein. The beads were then resuspended in Laemmli loading buffer and boiled 5 min at 95°C. Western blots were performed to detect FLAG-tagged proteins (detection of the interaction) and GST-fused proteins (determination of the abundance of GST-protein attached to the beads).
O-GlcNAc coprecipitation
Seven hundred thousand HEK293T cells were seeded per well in a 6-well plate and were transfected with 1 lg of DNA/well as described above. Forty-eight hours after transfection, cells were rinsed once with PBS and lysed in cold IP buffer (20 mM HEPES, 150 mM NaCl, 0.5 mM EGTA, 0.5% NP40) supplemented with 1x Complete TM protease inhibitor (#11873580001, Roche), during 20 min on ice with gentle agitation. Cell lysates were centrifuged 5 min at 16 000 g in a table centrifuge at 4°C. Expression of FLAGor GST-fused proteins and O-GlcNAcylated proteins were analysed by western blotting with a mouse anti-FLAG antibody (#F1804, Sigma), a mouse anti-GST antibody (#G1160, Sigma) and a mouse anti-O-GlcNAc antibody (#sc-59624, Santa Cruz, Dallas, TX, USA), respectively. Fifty lL of protein A agarose beads (#11719408001, Sigma) was washed three times with cold IP and then added to protein lysates 1 h at 4°C on a rotating wheel. After centrifugation (2 min, 1000 g, 4°C), protein lysates were collected and incubated 1 h on a rotating wheel at 4°C with 1 lg of mouse anti-O-GlcNAc antibody or mouse IgG control antibody (#12-371, Millipore, Molsheim, France). Then, new beads, prewashed with cold IP, were added to the protein lysates -antibody solution during 4 h on a rotating wheel at 4°C. Beads were then washed three times with cold IP. The beads were then resuspended in Laemmli loading buffer and boiled 5 min at 95°C. Supernatant was analysed by western blot for HOXA1 detection with a rabbit anti-HOXA1 antibody (#HPA004933, Sigma).
Peptide preparation for mass spectrometry
Mass spectrometry experiments were carried out with cell extracts arising from GST HOXA1 and OGT expressed in HEK293T cells, processed through precipitation on glutathione beads and SDS/PAGE as described above. 
LC-MALDI analysis
Peptide separation using nanoHPLC 
MALDI MS analysis
MS analysis was performed on an ABSciex 4800 MALDI time-of-flight (TOF)/TOF analyser using a 200 Hz solidstate laser operating at 355 nm. MS spectra were obtained in the m/z range of 800-4000. MS/MS spectra were obtained by automatic selection of the 15 most intense precursor ions per spot. Collision-induced dissociation was performed with an energy of 1 kV with air as the collision gas at a pressure of 1 9 10 6 Torr. Data were collected using the ABSCIEX 4000 SERIES EXPLORER TM software (Framingham, MA, USA).
MALDI processing data
Liquid chromatography-tandem MS (LC-MS/MS) data were processed using PROTEINPILOT TM 4.5 software and the Paragon TM search algorithm: 4.5.0.0,1654 (ABSciex). The MS/MS data were used to search on the local database containing protein of interest sequence. Thorough search option, propionamide as the fixed cysteine modification, oxidation as the variable methionine modification, OGlcNAc as the variable serine and threonine modification, phosphorylation as the variable serine, threonine and tyrosine modification and chymotrypsin as the digestion enzyme were selected in the ProteinPilot method. All reported proteins were identified with 95% or greater confidence, as determined by ProteinPilot unused scores (>1.3).
LC-IMS (ion mobility separation)-QTOF-MS (HDMS E )
Peptide separation using nanoUPLC
Peptide mixture in 0.1% (v/v) formic acid was separated by reverse phase chromatography on a NanoACQUITY UPLC MClass system (Waters, Milford, MA, USA) working with MASSLYNX V4.1 (Waters) software. Digested proteins were injected on a trap C18, 100 A 5 lm, 180 lm 9 20 mm column (Waters) and desalted using isocratic conditions with at a flow rate of 15 lL/min using a 99% formic acid and 1% (v/v) ACN buffer for 3 min. Peptide mixture was subjected to reverse phase chromatography on a C18, 100 A 1.8 lm, 75 lm 9 150 mm column (Waters) PepMap for 120 min at 35°C at flow rate of 300 nLÁmin À1 using a two part linear gradient from 1% (v/v) ACN, 0.1% formic acid to 35% (v/ v)) ACN, 0.1% formic acid and from 35% (v/v) ACN, 0.1% formic acid to 85% (v/v)) ACN, 0.1% formic acid.
HDMS E analysis
IMS-HDMS E (Ion Mobilty Separation-High Definition
Enhanced) analysis was performed on an SYNAPT G2-Si high definition mass spectrometer (Waters) equipped with a NanoLockSpray dual electrospray ion source (Waters). 
ESI-QTOF data processing
HDMS E data were processed with PROGENESIS QI (Nonlinear DYNAMICS, Waters) software using a local database containing protein of interest sequence. Propionamide as the fixed cysteine modification, oxidation as the variable methionine modification, O-GlcNAc as the variable serine and threonine modification, phosphorylation as the variable serine, threonine and tyrosine modification and chymotrypsin as the digestion enzyme were selected.
Results
Confirmation of the interaction between HOXA1 and OGT
To validate the interaction detected by yeast-two-hybrid [32] , coprecipitation assays were performed in transfected HEK293T cells. The OGT protein was fused to Glutathione-S-Transferase ( GST OGT) and coexpressed with a FLAG-tagged HOXA1 ( FLAG HOXA1). The GST-fused protein was then purified on glutathionesepharose beads and the interaction was assessed by coprecipitation of the FLAG HOXA1. Cells transfected with unfused GST and FLAG HOXA1 were used to control nonspecific interaction. FLAG HOXA1 was successfully detected after precipitation of GST OGT but not with GST (Fig. 1A, lanes 1-2) . Protein coprecipitation on glutathione beads was also performed with reciprocal protein fusions, i.e. with FLAG OGT and GST HOXA1 and allowed retrieving FLAG OGT after GST HOXA1 precipitation (Fig. S1) .
In order to determine the cell compartment where the interaction takes place, BiFC assays were carried out. OGT or GST alone were cotransfected in HEK293T cells. Forty-eight hours after transfection, cells were lysed and expression of FLAG-and GST-fused proteins was analysed by western blotting ('input'). The interaction was evaluated by the presence of FLAG HOXA1 after coprecipitation on glutathione beads ('CoP'). Provided blots are representative of at least three independent experiments. (B) Schematic representation of mouse HOXA1 deletion and mutant derivatives. HOXA1
DNter is deleted from its 40 first amino acid residues; HOXA1 D11His lacks the eleven-histidine (11-His)
repeat, HOXA1 D11-5His lacks the two stretches of histidines (11-His and 5-His; dark grey and light grey boxes, respectively); HOXA1 Fig. 2A shows that fluorescence complementation occurred only upon combining VC HOXA1 and VN OGT, thereby confirming their interaction. This interaction mainly took place in the nucleus, but sometimes some signal could also be detected in the cytoplasm (Fig. 2A) for the DNA recognition, and the hexapeptide (HP), displayed by HOX proteins of the paralogy groups 1 to 8, important for its interaction with its cofactors PBX. Moreover, HOXA1 possesses two long stretches of histidines (11-His and 5-His repeats) in its N-terminal portion (Fig. 1B) . Changes in the 11-His repeat sequence have been associated to different diseases and recently we have shown that this 11-His stretch is important for the HOXA1-mediated activation of the NF-jB pathway [18, 47, 48] . Six deletion derivatives of HOXA1 were generated: HOXA1 DNter , lacking its 40 N-terminal residues; HOXA1
D11His
, deleted of its 11-His repeat; HOXA1
D11-5His
, in which a region extending from the 11-His to the 5-His motifs was removed; HOXA1 D71-199 , lacking the central region of the protein from the 11-His repeat to the hexapeptide; HOXA1 HD+Cter , consisting in the homeodomain and the C-terminal extension of the protein; and HOXA1
DHD , devoid of the complete homeodomain. In addition, point mutations at the level of the hexapeptide resulted in a HOXA1 variant unable to interact with PBX (HOXA1 WM-AA ) [29] [30] [31] , and amino acid substitutions in the recognition helix of the homeodomain were generated to invalidate HOXA1 DNA binding (HOXA1 WFQN-SVAA ) [27, 30] (Fig. 1B) . HEK293T cells were cotransfected with GST OGT and FLAG HOXA1 derivatives. Although some variations could be observed for the protein abundance between HOXA1 variants in transfected cells, they were all retrieved upon coprecipitation with GST OGT (Fig. 1A,  lanes 3-18) , except FLAG HOXA1
HD+Cter (Fig. 1A,  lanes 11-12) . This supports that the interaction requires motifs or structural determinants located in the N-terminal part of HOXA1.
The HOXA1 variants were next fused to the VC fragment of Venus to proceed with BiFC experiments. All VC-fusion proteins were properly expressed as revealed by immunofluorescence (Fig. 2B) 
HOXA1
HD+Cter mutants did not allow detectable or showed severely impaired interaction with VN OGT. This suggests that at least two motifs could contribute to the interaction, namely the 11-His repeat and a sequence determinant residing between residues 71 and 199. This also supports that the BiFC assay was sensitive to the deletion of each of both motifs, which was not the case for coprecipitation showing a severe loss of interaction only with FLAG
HD+Cter . In addition, HOXA1
DHD and HOXA1 WFQN-SVAA , both impaired for their ability to bind DNA, interacted with OGT mainly in the cytoplasm ( Fig. 2A) , while the remaining variants and the WT HOXA1 displayed nuclear interaction. Collectively, these experiments indicate that the 11-His repeat and the region comprised between the 11-His stretch and the hexapeptide are important for the interaction between HOXA1 and OGT, and that when HOXA1 cannot bind to DNA the interaction preferably takes place in the cytoplasm. As a corollary, this suggests that under WT conditions, the OGT-HOXA1 interaction takes place on the DNA.
OGT is a 1046 residue-protein composed of several tetratricopeptide repeats (TPR, aa 1-473), a signal for nuclear localisation (NLS, aa 487-503) and a catalytic region (CAT, aa 991-1010). Four GHOXA1 after precipitation at a higher level than the background FLAG HOXA1 retrieval with GST alone (Fig. 3B) . In contrast, GST 
OGT
DTPR was highly expressed and provided only very low FLAG HOXA1 precipitation, supporting that deleting the tetratricopeptide repeats severely impaired the OGT-HOXA1 interaction. This loss of interaction was not due to the fact that the mutant did not fix glutathione beads (Fig. S2) . For BiFC, expression of the VN OGT mutants was verified by immunofluorescence (Fig. 3C) . Confirming the coprecipitation experiments, VN OGT TPR and VN OGT TPR-NLS sustained fluorescence complementation (Fig. 3D) . These interactions took place in the nucleus (Fig. 3D) . BiFC experiments also confirmed that removal of TPR (
GST OGT
DTPR
) provoked a loss of interaction with HOXA1 (Fig. 3D) . Finally, VN OGT DCAT did not or poorly interacted with VC HOXA1 (Fig. 3D) . Taken together, the results obtained with the OGT mutants reveal that the TPR domain is important to maintain the interaction with HOXA1. Moreover, the catalytic domain of OGT could also contribute to the interaction.
OGT post-translationally modifies HOXA1
OGT being an O-GlcNAc transferase, we investigated whether it could post-translationally modify HOXA1. OGT are active in HEK293T-cells (Figs 4A and S3) .
Next, immunoprecipitation against the O-GlcNAcylation modification in cells coexpressing GST HOXA1 and FLAG OGT was performed. By western blotting, we detected GST HOXA1 after precipitation when both proteins were coexpressed (Fig. 4A) , supporting that GST HOXA1 was O-GlcNAcylated. However, the GST moiety of GST HOXA1 could be O-GlcNAcylated and promote immunoprecipitation rather than the HOXA1 protein per se. Moreover, the GST moiety could also interfere, either positively or negatively, with HOXA1 folding and accessibility for O-GlcNAcylation. We thus repeated the experiment with FLAG HOXA1. Among the O-GlcNAcylated immunoprecipitated proteins, we could detect a small amount of FLAG HOXA1 (Fig. S3) .
To characterise the possible O-GlcNAcylation of HOXA1, we performed mass spectrometry (MS) analysis. Protein precipitation on glutathione beads was performed on lysates of HEK293T cells transfected with GST HOXA1 alone or in the presence of FLAG OGT. Proteins were loaded on a SDS polyacrylamide gel and the band corresponding to GST HOXA1 was recovered from the gel. GST HOXA1 was then digested by chymotrypsin. The resulting peptides were separated by nanoreverse phase HPLC and analysed by MS. First, we performed a LC-MALDI-TOF/TOF analysis that indicated existing modifications on the HOXA1 peptide 146 AGGTVGSPQYIHHSY 160 . To refine the analysis, data acquisition by HDMS E was carried out by ESI-QTOF-MS that revealed that this peptide was both phosphorylated and O-GlcNAcylated. The O-GlcNAc adduct was detected on peptide fragments containing the Thr149 residue (Fig. 4B) . One phosphorylation was also observed on this peptide. Phosphorylation could occur at different residues but fragments with this modification contain either Thr149 or Ser152 (Fig. 4C) . To sum up, HDMS E analysis suggests that HOXA1 peptide 146 AGGTVGSP-QYIHHSY 160 is O-GlcNAcylated at the residue Thr149 or phosphorylated at residues Thr149 or Ser152. Interestingly, the phosphorylation on the peptide appeared to be more abundant when GST HOXA1 was expressed alone (about 2.8 times more) than in the presence of OGT (Fig. 4D) . Conversely, abundance of O-GlcNAcylation showed the opposite tendency, less Thr149 O-GlcNAcylated peptide was detected with GST HOXA1 alone (about 16 times less) than upon OGT transfection (Fig. 4D) . Of note, this peptide without modifications was also detected, at the same relative abundance in the absence or in the presence of OGT.
To validate these results, the same experiment was performed with mutant OGT proteins: FLAG OGT DTPR , which has lost its ability to interact with GST HOXA1 (Figs 3B,D) , and FLAG OGT DCAT , a mutant which is catalytically dead (Fig. 3A) . As expected, O-GlcNAcylation on the AGGTVGSPQYIHHSY peptide was not detected with mutant OGT proteins, showing that the catalytic and the TPR domains of OGT are important to modify HOXA1 (Fig. 4D) . Consistently, phosphorylation at the Thr149 or Ser152 was correlatively more detected when OGT was impaired in its ability to interact with or to modify GST HOXA1 (Fig. 4D ). To conclude, HOXA1 is modified by phosphorylation and O-GlcNAcylation and these modifications were never detected together on the peptide AGGTVGSP-QYIHHSY, suggesting a cross-talk between phosphorylation and O-GlcNAcylation.
OGT does not affect the localisation, stability or intrinsic transcriptional activity of HOXA1
To gain insight into the consequences of the interaction between OGT and HOXA1, we tested the localisation, the stability and the intrinsic activity of HOXA1 upon OGT addition.
It is known that OGT can modulate the intracellular distribution of transcriptional factors, typically by influencing their nucleo-cytoplasmic shuttling [43, [49] [50] [51] [52] . Therefore, we evaluated the influence of OGT on the localisation of HOXA1 by performing immunofluorescence against FLAG HOXA1 in HEK293T transfected (Fig. 5A ). In addition, the intracellular localisation of GST OGT was also not affected by the presence of HOXA1 (Fig. 5A) . Thus, both proteins do not affect each other distribution in cells.
The O-GlcNAc modification is also known to, in some circumstances, increase the stability of target proteins under some circumstances [43, [53] [54] [55] [56] . To investigate whether OGT stimulates or prevents the degradation of HOXA1, we measured its turnover rate by cycloheximide (CHX) treatment. First experiments of half-life were performed in HEK293T cells and the abundance of HOXA1 did not decrease upon the time course of the experiment even in the presence of OGT (data not shown). The cycloheximide experiments were therefore repeated in NiH3T3 cells, a mouse cell line. NiH3T3 cells were transiently transfected with FLAG HOXA1 and, after 24 h, treated with cycloheximide to prevent de novo protein synthesis. Cell extracts were collected and analysed by western blot for HOXA1 abundance after 0-to 24 h. Again, the abundance of HOXA1 did not or hardly decreased upon the time course of the experiment (Fig. 5B) . In order to determine if OGT affects the long stability of HOXA1, we transfected FLAG HOXA1 with GST OGT in NIH3T3 cells. The presence of GST OGT had no impact on HOXA1 half-life (Fig. 5B) . To conclude, HOXA1 displays a long half-life and this half-life is not detectably affected by the presence of OGT.
As an interactor of HOXA1, OGT could influence its ability to activate transcription [33, 43, [57] [58] [59] . To assess the intrinsic capacity of a transcription factor to stimulate or inhibit gene expression, activity of target reporter genes like luciferase can be quantified. The HOXA1 target enhancers used to drive luciferase expression were derived from the well-characterised HOXA1 target genes EphA2 and Hoxb1 [24] [25] [26] . Activity tests were performed in HEK293T cells with FLAG OGT alone or in the presence of HOXA1.
FLAG OGT alone did not activate transcription whatever the reporter used (Fig. 5C ). In addition, FLAG OGT did not appear to affect the transcriptional activity of HOXA1 on any of both enhancers (Fig. 5C ). Since HOXA1 activity is known to be influenced by its partnership with PBX (see Fig. 5C , HOXA1 alone could not activate the EphA2-r4-luc reporter), the same experiments were performed in the presence of PBX1A. PREP1 was also added because this TALE family member protein promotes PBX proteins to access the nucleus [60] . HOXA1 activated transcription in the presence of its cofactors, whatever the reporter used. FLAG OGT had no significant impact on this transcriptional activation. To conclude, FLAG OGT does not seem to influence the ability of HOXA1 to activate transcription.
Discussion
Here, we have (a) confirmed the interaction between the O-GlcNAc transferase OGT and the transcription factor HOXA1; we have (b) determined that N-terminal determinants of HOXA1, namely the 11-His repeat and a region comprised between the 11-His stretch and the hexapeptide, the TPR domain of OGT and possibly its catalytic region are required for this interaction; we have (c) demonstrated that OGT can mediate the O-GlcNAcylation of HOXA1 and (d) that this modification erases phosphorylation.
The functions of HOX proteins have been extensively studied since their discovery in the late 1970s. It appeared that although these proteins share a very well conserved DNA-binding domain, the homeodomain, and therefore bind similar DNA sequences, they exert quite specific functions in the developing embryo as well as in cell differentiation processes [6] . This raised the so-called 'HOX paradox' which remains unresolved but which implies that context-specific molecular interactions should provide some functional specificity to HOX proteins. Critically, a way to specifically modulate the activity of transcription factors relies on their possible PTM. Activity regulation of HOX proteins by PTM has surprisingly been very scarcely investigated. Among the 39 mammalian HOX proteins, a few have been well described for some PTM. It is the case of HOXA10 [61] [62] [63] [64] and HOXA9 [65] [66] [67] [68] , for example. HOXA9 and HOXA10 are phosphorylated and this PTM affects their stability, DNA binding and transcriptional activity.
To our knowledge, no PTM has been highlighted so far for HOXA1. Here, we have shown that HOXA1 can be both phosphorylated and O-GlcNAcylated on its 146 AGGTVGSPQYIHHSY 160 peptide sequence. The O-GlcNAcylation takes place on the Thr149 and a single phosphorylation has been detected to occur on either Thr149 or Ser152, as determined by MS. Adduct of O-GlcNAcylation affects the activity of a multitude of proteins, among which transcription factors. For example, the nucleo-cytoplasmic shuttling of NeuroD1 is dictated by its O-GlcNAcylation status [52] and the O-GlcNAcylation of the NF-jB subunit p65 impacts on its interaction with the I-jBa inhibitor which in turn leads to an increase in NF-jB nuclear translocation [50, 69] . In addition, a cross-talk between O-GlcNAcylation and phosphorylation can take place to influence transcription factor properties [33, 43, 70] . For instance, the DNA binding of C/EBP b, a leucine zipper transcription factor, is impaired by O-GlcNAcylation which prevents phosphorylations required for its interaction with DNA [71] . It is also the case of the oestrogen receptor b (ER-b) which is O-GlcNAcylated at Ser16, a residue that can also be phosphorylated [54, 72] . Mutation of this serine into alanine increases the half-life of ER-b whereas mutation in glutamic acid, mimicking constitutive phosphorylation, leads to ER-b degradation. It seems that phosphorylation and O-GlcNAcylation at Ser16 induce different conformational changes leading to the degradation or stabilisation of ER-b, respectively [56] .The localisation and the DNA-binding ability of ER-b are, however, not affected by these mutations [54] . A similar impact of OGT-mediated O-GlcNAcylation on ER-a and p53 stability has also been reported [53, 55] .
Although OGT interacts with and modifies HOXA1, we were not able to show that this could alter the nucleo-cytoplasmic localisation, stability or intrinsic transcriptional activity of HOXA1, while several examples in the literature provided evidence that OGT can in fact modify transcription factor behaviour at these levels [33, 43] . Luciferase assays did not reveal any effect of OGT on the ability of HOXA1 to bind to target enhancers and stimulate transcription. This assay, however, relies on the activity of target genes residing on transfected plasmids which are not organised in molecular complexes mimicking a genuine chromatin structure. This limitation could mask the influence OGT exerts on HOXA1 activity in the integrated context of the chromatin, i.e. with histones, coregulators and additional HOXA1 interactors contributing to its action on endogenous target genes. In addition, it is probable that the interaction with OGT and/or PTM of HOXA1 modulate its activity in the context of a subset and not all of its targets. By chromatin immunoprecipitation and deep sequencing (ChIP-seq), Vella et al. recently revealed genes to which OGT binds in embryonic stem cell and identified MafB, Hnf1b and Hoxb1, three key regulators working together with Hoxa1 in hindbrain segmentation and patterning [73] . Like Hoxa1, Hoxb1, MafB and Hnf1b are expressed in the fourth hindbrain segment (or rhombomere) in the mouse embryo [74] . Hoxb1 is a well-established HOXA1 direct target gene in the hindbrain [25, 26] and MafB and Hnf1b have also been shown to be downstream targets of HOXA1-dependent genetic pathways [12, 21, 75] . It can therefore be hypothesised that OGT is present on target genes of HOXA1 and participates to gene modulation involved in the establishment of the fourth rhombomere. Identification of the possible co-occurrence of OGT and HOXA1 on these target genes deserves further investigation. The influence of OGT on HOXA1 activity could be direct, i.e. OGT could modulate the ability of HOXA1 to trigger transcription activation [76] , like it has been shown to happen for other transcription factors (reviewed in [33, 43] ). OGT's influence could also be indirect, through histone modifications or recruitment of additional (co-) regulators.
Finally, it should not be excluded that the HOXA1-OGT interaction might modulate OGT activities rather than that of HOXA1. HOX proteins are basically studied as transcription factors, but some evidence has demonstrated that these proteins also possess nontranscriptional activities [18, [77] [78] [79] . It is therefore possible that HOXA1 modulates the activity of OGT independently of being a transcription factor.
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